Opus Capital Group’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$116K	Hold	37,700	–	–	0.01%	133
2025 Q4	$134K	Buy	37,700 +3,000	+9%	+$18.4K	0.01%	130
2025 Q3	$309K	Hold	34,700	–	–	0.03%	98
2025 Q2	$320K	Hold	34,700	–	–	0.04%	92
2025 Q1	$298K	Hold	34,700	–	–	0.04%	95
2024 Q4	$373K	Buy	34,700 +2,000	+6%	+$15.4K	0.05%	84
2024 Q3	$186K	Hold	32,700	–	–	0.02%	116
2024 Q2	$138K	Buy	32,700 +2,200	+7%	+$8.9K	0.02%	115
2024 Q1	$155K	Hold	30,500	–	–	0.02%	119
2023 Q4	$284K	Hold	30,500	–	–	0.05%	100
2023 Q3	$200K	Buy	30,500 +4,000	+15%	+$31.8K	0.04%	110
2023 Q2	$215K	Hold	26,500	–	–	0.04%	115
2023 Q1	$227K	Hold	26,500	–	–	0.04%	110
2022 Q4	$245K	Buy	26,500 +10,000	+61%	+$107K	0.05%	103
2022 Q3	$170K	Hold	16,500	–	–	0.04%	105
2022 Q2	$165K	Hold	16,500	–	–	0.03%	109
2022 Q1	$203K	Hold	16,500	–	–	0.04%	106
2021 Q4	$286K	Hold	16,500	–	–	0.06%	88
2021 Q3	$296K	Buy	16,500 +6,000	+57%	+$119K	0.07%	83
2021 Q2	$240K	Buy	10,500 +500	+5%	+$7.41K	0.05%	102
2021 Q1	$150K	Hold	10,000	–	–	0.04%	124
2020 Q4	$54K	Hold	10,000	–	–	0.01%	127
2020 Q3	$46K	Buy	+10,000	New	+$43K	0.01%	116